These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 23164431)

  • 21. Expression of cAMP response element-binding protein in major depression before and after antidepressant treatment.
    Lai IC; Hong CJ; Tsai SJ
    Neuropsychobiology; 2003; 48(4):182-5. PubMed ID: 14673215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced phosphorylation of cyclic AMP-responsive element binding protein in the postmortem orbitofrontal cortex of patients with major depressive disorder.
    Yamada S; Yamamoto M; Ozawa H; Riederer P; Saito T
    J Neural Transm (Vienna); 2003 Jun; 110(6):671-80. PubMed ID: 12768362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The value of ethyl cysteinate dimer single photon emission computed tomography in predicting antidepressant treatment response in patients with major depression.
    Hanada H; Imanaga J; Yoshiiwa A; Yoshikawa T; Tanaka Y; Tsuru J; Inoue A; Ishitobi Y; Okamoto S; Kanehisa M; Maruyama Y; Ninomiya T; Higuma H; Isogawa K; Kawasaki T; Fujioka T; Akiyoshi J
    Int J Geriatr Psychiatry; 2013 Jul; 28(7):756-65. PubMed ID: 23007970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective Serotonin Reuptake Inhibitors and Serotonin and Noradrenaline Reuptake Inhibitors Improve Cognitive Function in Partial Responders Depressed Patients: Results from a Prospective Observational Cohort Study.
    Castellano S; Ventimiglia A; Salomone S; Ventimiglia A; De Vivo S; Signorelli MS; Bellelli E; Santagati M; Cantarella RA; Fazio E; Aguglia E; Drago F; Di Nuovo S; Caraci F
    CNS Neurol Disord Drug Targets; 2016; 15(10):1290-1298. PubMed ID: 27712575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pretreatment regional brain glucose uptake in the midbrain on PET may predict remission from a major depressive episode after three months of treatment.
    Milak MS; Parsey RV; Lee L; Oquendo MA; Olvet DM; Eipper F; Malone K; Mann JJ
    Psychiatry Res; 2009 Jul; 173(1):63-70. PubMed ID: 19446443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. cAMP signaling in brain is decreased in unmedicated depressed patients and increased by treatment with a selective serotonin reuptake inhibitor.
    Fujita M; Richards EM; Niciu MJ; Ionescu DF; Zoghbi SS; Hong J; Telu S; Hines CS; Pike VW; Zarate CA; Innis RB
    Mol Psychiatry; 2017 May; 22(5):754-759. PubMed ID: 27725657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective phosphorylation of nuclear CREB by fluoxetine is linked to activation of CaM kinase IV and MAP kinase cascades.
    Tiraboschi E; Tardito D; Kasahara J; Moraschi S; Pruneri P; Gennarelli M; Racagni G; Popoli M
    Neuropsychopharmacology; 2004 Oct; 29(10):1831-40. PubMed ID: 15138445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mitogen activation of human peripheral T lymphocytes induces the formation of new cyclic AMP response element-binding protein nuclear complexes.
    Wollberg P; Söderqvist H; Nelson BD
    J Biol Chem; 1994 Aug; 269(31):19719-24. PubMed ID: 8051051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pre-treatment allostatic load and metabolic dysregulation predict SSRI response in major depressive disorder: a preliminary report.
    Hough CM; Bersani FS; Mellon SH; Morford AE; Lindqvist D; Reus VI; Epel ES; Wolkowitz OM
    Psychol Med; 2021 Sep; 51(12):2117-2125. PubMed ID: 32438932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum brain-derived neurotrophic factor and glucocorticoid receptor levels in lymphocytes as markers of antidepressant response in major depressive patients: a pilot study.
    Rojas PS; Fritsch R; Rojas RA; Jara P; Fiedler JL
    Psychiatry Res; 2011 Sep; 189(2):239-45. PubMed ID: 21616544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oxcarbazepine and fluoxetine protect against mouse models of obsessive compulsive disorder through modulation of cortical serotonin and CREB pathway.
    Arora T; Bhowmik M; Khanam R; Vohora D
    Behav Brain Res; 2013 Jun; 247():146-52. PubMed ID: 23473877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Higher serum DHEA concentrations before and after SSRI treatment are associated with remission of major depression.
    Hough CM; Lindqvist D; Epel ES; Denis MS; Reus VI; Bersani FS; Rosser R; Mahan L; Burke HM; Wolkowitz OM; Mellon SH
    Psychoneuroendocrinology; 2017 Mar; 77():122-130. PubMed ID: 28038403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Edivoxetine compared to placebo as adjunctive therapy to selective serotonin reuptake inhibitors in the prevention of symptom re-emergence in major depressive disorder.
    Oakes TM; Dellva MA; Waterman K; Greenbaum M; Poppe C; Goldberger C; Ahl J; Perahia DG
    Curr Med Res Opin; 2015 Jun; 31(6):1179-89. PubMed ID: 25894953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alterations in phosphorylated cAMP response element-binding protein (pCREB) signaling: an endophenotype of lithium-responsive bipolar disorder?
    Alda M; Shao L; Wang JF; Lopez de Lara C; Jaitovich-Groisman I; Lebel V; Sun X; Duffy A; Grof P; Rouleau GA; Turecki G; Young LT
    Bipolar Disord; 2013 Dec; 15(8):824-31. PubMed ID: 24238631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Saliva levels of 3-methoxy-4-hydroxyphenylglycol and clinical efficacy of mirtazapine or selective serotonin reuptake inhibitors in patients with major depression.
    Egami M; Imamura Y; Nabeta H; Mizoguchi Y; Yamada S
    Hum Psychopharmacol; 2013 Jan; 28(1):7-14. PubMed ID: 23124792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frontoparietal Activation During Response Inhibition Predicts Remission to Antidepressants in Patients With Major Depression.
    Gyurak A; Patenaude B; Korgaonkar MS; Grieve SM; Williams LM; Etkin A
    Biol Psychiatry; 2016 Feb; 79(4):274-81. PubMed ID: 25891220
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spotlight on sertraline in the management of major depressive disorder in elderly patients.
    Muijsers RB; Plosker GL; Noble S
    CNS Drugs; 2002; 16(11):789-94. PubMed ID: 12383038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of treatment response in geriatric depression from baseline folate level: interaction with an SSRI or a tricyclic antidepressant.
    Alpert M; Silva RR; Pouget ER
    J Clin Psychopharmacol; 2003 Jun; 23(3):309-13. PubMed ID: 12826993
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Algorithm-based treatment of major depression in an outpatient clinic: clinical correlates of response to a specific serotonin reuptake inhibitor and to triiodothyronine augmentation.
    Agid O; Lerer B
    Int J Neuropsychopharmacol; 2003 Mar; 6(1):41-9. PubMed ID: 12899735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxidative stress, inflammation and treatment response in major depression.
    Lindqvist D; Dhabhar FS; James SJ; Hough CM; Jain FA; Bersani FS; Reus VI; Verhoeven JE; Epel ES; Mahan L; Rosser R; Wolkowitz OM; Mellon SH
    Psychoneuroendocrinology; 2017 Feb; 76():197-205. PubMed ID: 27960139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.